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Abstract.
Background: In attempting to formulate potential WHO guidelines for the diagnosis of male infertility, the 
Evidence Synthesis Group noted a paucity of high quality data on which to base key recommendations. As 
a result, a number of authors suggested that key areas of research/evidence gaps should be identified, so 
that appropriate funding and policy actions could be undertaken to help address key questions. 
Objectives: The overall objective of this Consensus workshop was to clarify current knowledge and deficits 
in clinical laboratory andrology, so that clear paths for future development could be navigated.  
Materials and Methods: Following a detailed literature review, each author, prior to the face to face 
meeting, prepared a summary of their topic and submitted a PowerPoint presentation. The topics covered 
were (1) Diagnostic testing in male fertility and infertility (2) Male fertility/infertility in the modern world 
(3) Clinical management of male infertility and (4) The overuse of ICSI. At the meeting in Cairo on 18th 
February 2019 the evidence was presented and discussed and a series of consensus points agreed.  
Results: The paper presents a background and summary of the evidence relating to these four topics and 
addresses key points of significance. Following discussion of the evidence, a total of 36 consensus points 
were agreed.  
Discussion: The Discussion section presents areas where there was further debate and key areas that 
were highlighted during the day.  
Conclusion:  The consensus points provide clear statements of evidence gaps and/or potential future 
research areas/topics. Appropriate funding streams addressing these can be prioritized and consequently, 
in the short and medium term, answers provided. By using this strategic approach Andrology can make 
the rapid progress necessary to address key scientific, clinical and societal challenges that face our 
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Background to the consensus document. 
The Evidence Synthesis Group formulating potential World Health Organization (WHO) guidelines for the 
diagnosis of male infertility noted a paucity of high quality data on which to base key recommendations 
(Barratt et al. 2017). Remarkably, even with basic questions, there was not sufficient data to formulate 
“low”, much less “strong”, recommendations.  Moreover, fundamental deficiencies were evident   
regarding longstanding questions. Overall this was deemed symptomatic of a much broader “andrological 
ignorance” (Barratt et al. 2017; 2018).
Suffice it to say that there is a fundamental lack of knowledge that substantially obstructs research, 
diagnosis and patient management. Yet paradoxically male infertility is part of a dynamic and growing 
health industry within which ART is a highly innovative, billion-dollar enterprise. Reproductive medicine 
rapidly attracts the attention of the general public and, as such, the perception is that significant progress 
has been made.  This is an illusion as, for example, numerous basic, clinical and scientific questions in 
andrology have remained unanswered – some for over 50 years (Barratt et al., 2018, De Jonge and Barratt 
2019). 
Following the first birth of an ICSI conceived child in 1992, use of ICSI worldwide has increased 
dramatically and the treatment is increasingly used even when no male problem is present (Adamson et 
al. 2018; Dyer et al., 2019). But ICSI treatment is paradoxical: ICSI does not treat male fertility as the man’s 
fertility status remains unchanged (only the gametes are manipulated), the woman largely carries the 
treatment burden for male infertility.  Furthermore, and ironically, many authors argue that the success of 
ICSI has focused research onto the female (to optimize the ART process) and thus diverted attention away 
from identifying the causes and thus rational diagnosis and treatment of male infertility (Aitken 2018). 
Recently, we detailed how this parlous situation was reached, and suggested how we might move forward 
in a structured way to improve our understanding and management of male reproductive health issues 
(Barratt et al. 2018). One component of this was to suggest an analysis of the underlying deficits in our 
knowledge of clinical laboratory andrology and to identify strategies whereby medical and scientific 
research might seek to fill these gaps.  In so doing we can start to build a sound foundation for the future 
of andrology as a biomedical specialty:  a future in which the male partner in infertile couples is seen as a 
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male factor infertility, and in which political leaders understand how poor product regulation and neglect 
and mismanagement of our environment are impacting human fertility, and health in general.
The overall aim of this Consensus workshop (see table 1 for details of participants) was to clarify the 
current deficits in knowledge so that clear paths for future development could be navigated.  Following 
presentation of the evidence a total of 36 consensus points are presented.
1. Workshop Session 1 - Diagnostic Testing in Male Fertility/Infertility
1.1 Semen analysis, standardization and reference ranges.
1.1.1 Origins of standardization in semen analysis 
Although the semen sample examined in the laboratory differs significantly to the situation in vivo it is the 
standard approach to assessment of male infertility.  The first protocol for analysis of human semen that 
could be considered as suitable for clinical laboratory testing came from Macomber & Sanders 
(Macomber & Sanders 1929). These investigators diluted a known volume of semen with a known volume 
of bicarbonate/formalin solution to “dissolve” seminal mucus and formalin to “stop the activity” of the 
spermatozoa. After mixing, an aliquot was placed in a blood counting chamber (hemocytometer) allowing 
calculation of the sperm concentration. They commented on sources of error in the technique and how to 
proceed when the sperm numbers were either very high or very low and concluded that “the 
spermatozoa count has proved a useful guide to fertility.” 
In the early 1950s a series of investigations on human semen quality were published that can arguably be 
credited with heralding modern andrology (Macleod & Gold 1951). Throughout these investigations close 
attention was paid to minimizing confounding variables. For example, the method for counting 
spermatozoa (hemocytometer) was standardized and a single, gold standard observer (the principal 
investigator) examined initial motility and counted all specimens. Semen samples from 1000 men of 
known fertility and 1000 men from infertile marriages were evaluated and purportedly, it was the results 
from this report that served as the basis for the reference ranges in the first WHO supported Laboratory 
Manual for the Examination of Human Semen (Belsey et al. 1980).  Since 1980, the WHO has published 









This article is protected by copyright. All rights reserved
(WHO 1987, 1992, 1999, 2010) in an attempt to align the discipline more closely with other standardized 
clinical laboratory practices. 
1.1.2 WHO (2010) reference values and their impact on clinical and laboratory practice 
Strict adherence, by multiple laboratories, to standardized methods for semen testing and evaluation 
makes data more easily comparable and analysis more statistically powerful, such that ranges of 
‘reference’ values can be derived. The 2010 WHO manual was the first to contain reference values derived 
from a large set of data (Cooper et al. 2010).   However, a limitation was their derivation from a limited 
demographic (Europe, Australia and US) and, in addition, there was variation in methods used for 
assessing critical semen parameters.  
Ideally, information provided by the WHO should facilitate meaningful interpretation of semen analysis 
data and conclusions about fecundity both for populations and individual patients. In the 2010 WHO 
manual the reference ranges were based on results from relatively few fertile men (428-1941) whose 
partners had a time-to-pregnancy of 12 months or less (Cooper et al. 2010). When reference ranges are 
calculated in clinical chemistry it is common to include 95% of obtained data, and usually, the 2.5th and 
97.5th centiles form the lower and upper reference limits. The rationale is that both too high and too low 
values may be considered harmful. However, as high values for semen parameters usually are not 
considered to impair fertility, the WHO guidelines use a one-tailed approach, basing the reference levels 
on the 5.0th centiles (World Health Organization, 2010). WHO emphasizes that “Men whose semen 
characteristics fall below the lower limits given are not necessarily infertile”. However, it cannot be 
concluded that a man will have a normal fertility chance if his semen parameters are above the reference 
ranges. Several studies have shown that fertilising ability diminishes if the sperm concentration is below 
40-50 million/ml, total sperm count below 140-150 million, the percentage of motile spermatozoa below 
70%, and percentage of morphologically normal spermatozoa below 9-12% (Bonde et al. 1998; Guzick et 
al. 2001; Slama et al. 2002). These values, which considerably exceed the WHO reference levels (15 
million/ml, 39 million, 40% and 4%, respectively) indicate levels at which ability to conceive may become 
impaired. It is probable that, in the future, sub-categories will need to be introduced to take account of 
this complexity. Additionally, semen quality must be considered as a continuum and models to predict 
fertility chances, rather than specific reference levels, must to be developed. Such models should also 
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data obtained from fertile men are relevant to guide us to understand the impact of semen quality. 
However, adding information from well-defined populations of men with fertility problems may also be 
relevant to calculation of risk-estimates for prolonged waiting time to pregnancies as would, for example, 
accounting for factors such as female factor and variation between ejaculates (Patel et al. 2018).
Unfortunately, the WHO (2010) reference values are often wrongly equated with indicating fertility if a 
sample exceeds all lower reference limits and infertile if it falls below the reference for one or more 
parameters.  A consequence of using reference values as cut offs is that, as new data emerge and 
reference values are refined, semen samples may change classification (Björndahl 2011, Murray et al 
2012). Importantly it is critical not to use one single semen parameter as a marker of male reproductive 
potential. Guzick et al. (2001) formulated three categories; subfertile, fertile and ‘indeterminate’. Odds 
ratios for infertility climbed dramatically from the combination of all ‘fertile’ combined sperm parameters 
(OR 1.0) to all subfertile sperm parameters (OR ~16). Sperm parameters in mixed combination had 
escalating odds ratios for infertility. The take home message was that significantly greater diagnostic 
ability comes when the sperm parameter assessments are combined rather than used individually (Barratt 
et al. 2017).
1.1.3 Compliance and quality 
To determine whether semen assessments are robust throughout the world requires that there are 
standardized methods used by clinical and research laboratories. Such standardized methods certainly 
exist but a wealth of data show that semen assessments, for a variety of reasons such as lack of 
adherence to methods, can have poor reproducibility (Björndahl et al., 2016; Carrell & De Jonge, 2016; 
Barratt et al. 2017; Nieschlag et al. 2017). As a result, a patient categorized as subfertile in one lab has 
reasonable likelihood of being categorized as fertile in another laboratory and vice versa. 
One potential way to correct for lack of standardization is by offering specialized training courses (e.g., 
Björndahl et al. 2002; Franken 2013). Statistical comparison of participant pre-training to post-training 
results clearly demonstrates a significant improvement. However, training must be supported by routine 
external quality assessment (EQA). EQA not only provides a mechanism for assessing testing proficiency of 
personnel but also compliance with standardized methods for testing. For example, a survey was 
conducted of andrology workshop-trained and certified staff and of non-certified laboratory staff working 
in Polish laboratories to assess compliance with WHO (2010) standards (Walczak-Jedrzejowska et al. 
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adherence to, WHO standards. In Italy, an analogous study was conducted in which technologists 
participated in three trials of EQA assessment. The results from this study showed a high degree of 
variation in methodology and proficiency, and this in spite of the fact that a training session was provided 
between trials 2 and 3 (Filimberti et al. 2013).
Clearly a greater unified effort toward continuous training and compliance to improve the standard and 
consistency of semen analysis is required. The beneficial effects of such compliance and adherence to 
standards is illustrated by the data of Punjabi who evaluated 15 years of results (1997-2012) from a 
voluntary EQA program in Belgium (Punjabi et al. 2016). Results showed that adoption by laboratories of 
the Neubauer hemocytometer as the standard sperm counting chamber resulted in a decrease in CV 
compared to other chambers used. This study demonstrates that long-term ‘buy-in’ by administration and 
laboratory staff to published professional standards leads to success. 
1.2 The current and future potential of sperm functional testing
To fertilize, a spermatozoon must penetrate cervical mucus, pass through the uterus, enter the oviduct 
and ascend to the site of fertilization (which probably involves binding to and active escape from the 
lining cells), locate the oocyte, undergo acrosome reaction, penetrate the cumulus and zona and fuse with 
the oocyte, forming the sperm aster and achieving syngamy (Publicover et al. 2007). These different 
aspects of the spermatozoon’s activity involve a wide variety of functional attributes, impairment of any 
of which might underlie a failure to fertilize. Tests of sperm attributes/fertilizing ability therefore address 
a wide range of functional characteristics e.g. motility/hyperactivation assessment, mucus penetration, 
zona pellucida interaction, acrosome reaction, oocyte penetration. In addition, biochemical assays and 
marker assays such as localization of membrane constituents (see below) can be used to assess 
characteristics believed to be correlated with sperm function.  Such tests will address one or more of 
these key functional attributes and aim to identify samples where a particular attribute (or attributes) are 
impaired. Since the aetiology of male infertility/subfertility can vary (both the functional defect(s) and the 
causative lesion(s)), such tests could detect subfertility related to a group of lesions with a common 
functional effect, but might nevertheless detect only a small subset of potential fertility-compromising 
defects. 
It is remarkable that little progress has been made on true sperm function tests since the 1980s/1990s 
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are reported to have potential clinical value but the literature is not consistent (e.g. questioning of both 
sensitivity and specificity in a recent meta-analysis (Xu et al. 2018)). Use of these tests often requires 
access to human biological material (zonae, cervical mucus) and involves complex manipulation requiring 
high levels of operator training. Moreover, biochemical assays often require technologies that are 
relatively expensive (e.g. flow cytometry, fluorescence plate reader) and/or low throughput. Computer 
aided sperm analysis (CASA) is potentially valuable but is also expensive to set up, requires training and is 
yet to be fully adopted in andrology laboratories (Mortimer et al. 2015).  Improvements in technology and 
development of standardized applications might improve this. To date, CASA has been used primarily for 
descriptive analysis but the development of functional assays (such as assessment of hyperactivation in 
capacitating or agonist-stimulated cells) should be an aim (Mortimer & Mortimer 2013; Mortimer et al. 
2015). Despite this overall lack of progress, there are a number of areas where recent advances suggest 
that progress in the development and application of new sperm functional tests could occur. These 
include proteomics of spermatozoa and the seminal plasma (Camargo et al. 2018), metabolomics and 
mitochondrial metabolism (Amaral et al. 2013; Reynolds et al. 2017; Calvert et al. 2019), novel markers of 
fertilizing ability e.g. the Cap test (Schinfeld et al. 2018) and the considerable progress being made in 
understanding of sperm physiology and cell signaling, particularly the expression and functions of 
spermatozoon ion channels. For illustrative purposes some examples are briefly considered below.
Mitochondrial status of live spermatozoa can be assessed using fluorescent dyes such as JC-1, either in 
single cells (by microscopy) or in populations (flow cytometry; (Pena et al. 2018)). Measurements made 
with JC-1 and other dyes have shown that mitochondrial membrane potential is correlated with markers 
of semen quality such as motility, viability, count and morphology (Espinoza et al. 2009; Zhang et al. 2016) 
but diagnostic/predictive value for fertilizing potential has not been established.
The Cap-score assay is based upon the relationship between localization of the ganglioside 
monosialotetrahexosylganglioside (GM1) and capacitation status. Spermatozoa which can undergo 
acrosome reaction are drawn from a sub-population that display a ‘capacitated’ GM-1 pattern where the 
ganglioside is localized apically (Cardona et al. 2017). The staining procedure is carried out on fixed cells 
so samples can be sent to a central laboratory allowing standardization. In a recent study where men 
likely to have trouble conceiving were identified using their Cap-score, the absolute pregnancy rate was 
almost three times higher in these men considered likely to conceive according to the previously-defined 
Cap-Score reference ranges (Schinfeld et al. 2018). However, the data are still preliminary and more 
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Krausz and colleagues (Krausz et al. 1995; 1996) first showed that the ability of progesterone to induce an 
immediate Ca2+-influx in human spermatozoa is correlated with fertilization rate at IVF. This action of 
progesterone is now known to reflect activation of CatSper, the primary Ca2+ channel of spermatozoa. 
Recent work has confirmed this finding and shown similar correlations with other agonists (Alasmari et al. 
2013; Kelly et al. 2018) but no attempt has yet been made to identify a predictive value (level of response 
below which fertilization failure is predicted). Men with no detectable [Ca2+]i response to progesterone 
(indicating no functioning CatSper) appear to be unable to fertilize naturally or by IVF and thus require 
ICSI, but extensive screening suggests that this condition is very rare, probably being less than 1% of IVF 
patients (Krausz et al. 1995; Krausz et al. 1996; Alasmari et al. 2013; Williams et al. 2015). A more 
common defect in spermatozoon ion channel function might be in regulation of plasma membrane 
potential (Vm). Brown and colleagues, using patch clamping to measure K+ currents and estimate Vm, 
found that in >10% of samples from IVF patients the membrane potential was abnormally depolarized and 
that a highly depolarized membrane potential (Vm≥0 mV) may be associated with low fertilization rate 
(Brown et al. 2016).
These and other new assays are potentially of considerable value, though in almost all cases the clinical 
value is yet to be assessed in large groups of patients. With regard to use in the clinic, the most useful 
tests will probably be prediction of IUI/IVF/ICSI failure although these are clearly different biological 
endpoints (Mortimer 1999; Sakkas et al., 2015).  Two areas of rapid progress provide grounds for guarded 
optimism: (i) real progress in our understanding of sperm physiology (and consequent identification of 
new parameters for assay) and (ii) improvement of high-throughput assay techniques, including 
simultaneous flow cytometry/fluorescent imaging. Development of multiplex tests for several sperm 
attributes, based on flow cytometry or plate reader methods (e.g. simultaneous detection of Cap-1 
pattern, AR,  CatSper expression, mitochondrial Vm) may enable more reliable assessment of sperm 
functional competence and probability of fertilization failure, facilitating selection of the most appropriate 
treatment pathway.  
1.3 Sperm DNA assessment
As sperm DNA fragmentation (sDF) is only partially related to semen quality it could be an important 
addition to the sperm function testing armamentarium (Evgeni et al., 2014, Muratori et al., 2015) 
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couple infertility (Santi et al. 2018). The most important issue emerging from this debate is the presence 
of several possible assays, many of them not standardized. These assays vary greatly both in the method 
and type of damage they are detecting.  The type of damage assessed by the different techniques is 
critical. Indeed, there is evidence that the indirect methods (Sperm Chromatin Structure Assay [SCSA] and 
sperm chromatin dispersion test [SCD; also known as Halosperm test]) detect the susceptibility of 
chromatin to undergo DNA damage and fragmentation, whereas more direct methods (TUNEL [Terminal 
deoxynucleotidyl transferase dUTP nick end labeling] and Comet [single cell gel electrophoresis assay]) 
actually assess the presence of breaks within the DNA.  
As the most important damage is that which affects reproductive outcomes, it is important to clearly 
define the relationship between the test used and the clinical outcome. This point has been addressed in 
recent meta-analyses (Robinson et al. 2012; Osman et al. 2015; Cissen et al. 2016; Simon et al. 2017; Tan 
et al. 2018; McQueen et al. 2019) where studies were grouped according to the different methods of 
assessment. When the miscarriage rate was considered as the endpoint, both after ARTs and natural 
pregnancies, the TUNEL method appeared to be the most useful, followed by SCSA (Robinson et al. 2012). 
A more recent meta-analysis considering couples with repeated pregnancy loss (RPL) following natural 
conception, revealed a similar, significant association both when TUNEL and SCD were used to evaluate 
sDF (Tan et al. 2019). McQueen and colleagues (2019) who also presented a systematic review and meta-
analyiss of RPL, concluded that TUNEL was the most appropriate sDF method. The meta-analysis by 
Osman where the endpoint was live birth rate after ARTs, suggested that TUNEL was the most clinically 
useful technique followed by Comet (Osman, et al. 2015). Cissen and colleagues (Cissen et al. 2016), who 
considered clinical pregnancy after IVF and ICSI as the endpoint, showed only TUNEL and Comet to be of 
‘fair discriminatory capacity’, whereas SCSA and SCD tests showed a ‘poor predictive capacity’. Finally, 
Simon et al. (2017) reported that TUNEL, Comet and SCD were predictive of clinical pregnancy after IVF 
and ICSI, with SCD being the least significant. Although the studies included in these meta-analyses differ 
considerably, and the female factor is often neglected they report evidence that SCSA and SCD have 
limited clinical value. Overall, these studies confirm that the different techniques detect different types of 
damage. 
The above conclusion is also supported by studies investigating the effect of sperm selection techniques 
on DNA integrity. For example, density gradient centrifugation (DGC) may provoke an increase of DNA 
damage in highly motile selected spermatozoa (Aitken et al. 2014; Muratori et al. 2016; Muratori et al. 
2019). However, in contrast to assessment using TUNEL, such an increase in DNA damage does not appear 
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Comet and SCD are also able to detect DNA damage after DGC. The scenario appears different in studies 
on natural conception (Zini 2011) and intrauterine insemination (IUI) (Chen et al. 2019), where SCSA 
results were found to be a reasonable predictor of pregnancy. However, overall, there is an urgent need 
for more primary data in this arena as meta- analyses are only as strong as the original data available. 
Another key challenge is that several different sDF threshold values have been proposed for 
discriminating between pathological and normal conditions. This inconsistency further contributes to the 
current confusion. At present, the only possibility is for each laboratory using sDF to set its own cut-off 
value, suitable for use with the established method, for distinguishing between fertile and sub- or infertile 
men. It is anticipated that, once further high quality clinical data are available, consensus guidelines can 
be developed to identify the gold standard method(s) to evaluate sDF for couple infertility work-up.
Emerging data in the literature suggest that several conditions are associated with high SDF levels 
including varicocele, unexplained infertility, recurrent IVF or ICSI failure, advanced age, diabetes, presence 
of inflammatory signs of the lower genital tract and cancer (Capogrosso et al. 2018; Hanson et al. 2018). 
Patients with these conditions might benefit from evaluation of SDF as diagnostic tool but, with the 
possible exception of varicocelectomy, effective treatments for diagnosed SDF remain to be determined. 
In conclusion, we are still some way from understanding how best to introduce the assessment of SDF 
into the male infertility work-up.  At least three important areas remain: (i) establishing the gold standard 
technique(s) for each reproductive outcome; (ii) finding effective pharmacological treatments to decrease 
clinically relevant sperm DNA damage in vivo; (iii) establishing correct strategies to prepare spermatozoa 
for ARTs to avoid iatrogenic damage. Suffice it to say there is a need for large-scale, robust, controlled 
trials on the value of sDF testing.
2. Workshop Session 2: Male Fertility/Infertility in the Modern World
The study by Carlsen suggesting that human sperm counts were in the process of significant decline 
(Carlsen et al. 1992), stimulated great interest whilst precipitating a lively and ongoing debate about the 
nature of the data analyzed and whether the interpretation was sound. Data analyzed in subsequent 
studies appear to confirm that this downward trend is real, at least in men of western countries (Levine et 










This article is protected by copyright. All rights reserved
2.1 Is male fertility really declining?
2.1.1 Temporal trends in semen quality
2.1.1.1 Meta analyses show a negative time trend in semen quality. Although a temporal trend in semen 
quality was discussed briefly in the 1970s (Nelson & Bunge 1974; MacLeod & Wang 1979) the current 
ongoing debate was started in 1992 by an analysis of semen quality data from 61 studies published 
between 1938 and 1990 (Carlsen et al. 1992). The authors concluded that there was “Evidence for 
decreasing quality of semen during past 50 years”. A re-analysis by Swan et al, which included data from a 
further 47 studies, corroborated the finding (Swan et al. 1997). In 2017, the most comprehensive meta-
analysis to date was published (Levine et al. 2017), incorporating 244 estimates of sperm concentration 
and total sperm counts, based on 185 studies (including studies on general [unselected] populations and 
on selected fertile men) of 42,935 men who provided semen samples between 1973 and 2011. Criteria for 
inclusion of studies covered semen collection methods, assessment methods and statistical analysis. Data 
analysis took account of age, ejaculation abstinence period and number of samples from each man. 
Trends did not differ among studies from Europe/Australia and America so these areas were combined 
into one group of Western men. The observed trends were dependent on the population group, the 
largest decline in semen quality being among the Western unselected men where there was a 1.4%/year 
decrease in sperm concentration (-1.38 million/ml/year; confidence interval -2.02 to -0.74) and 1.6%/year 
decrease in total sperm count (5.33 million/year; confidence interval -7.56 to –3.11). A less pronounced 
decrease was detected among the Western fertile men (sperm concentration -0.68 million/ml; confidence 
interval -1.31 to -0.05) and total sperm count (2.12 million/ml; confidence interval -4.31 to 0.07). When 
the analysis was restricted to data collected after 1995 the slopes were slightly steeper than for the entire 
period from 1973, arguing against an attenuation of the adverse trends. No conclusions could be reached 
about men from Non-Western countries primarily because few studies conducted in these areas have 
been carried out/reported.
2.1.1.2 Year of birth may be an important factor. Following the Carlsen publication in 1992, other research 
groups started to evaluate or re-evaluate data they had previously collected. Examination of 1,351 fertile 
semen donor candidates from Paris during a 20 year period showed a decrease in mean sperm 
concentration from 89 million/ml in 1973 to 60 million/ml in 1992 (Auger et al. 1995). After adjustment 
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in mean sperm concentration pointing to a birth cohort effect stronger than the effect of the year of 
examination (-2.1%). Furthermore, sperm motility and morphology were negatively associated with 
calendar year and year of birth, whereas semen volume was not. This study also showed the importance 
of accounting for confounders, since greater age was associated with a decreased sperm concentration, 
percentage of motile spermatozoa and percentage of morphologically normal spermatozoa, and 
ejaculation abstinence period was positively associated with sperm concentration and negatively with 
sperm motility. A subsequent Scottish study, investigating semen donor candidates and not restricted to 
men with proven fertility, similarly showed deterioration of semen quality as a consequence of later year 
of birth (Irvine et al. 1996). A study published in 2012 confirmed the decrease in a population of French 
fertile donors over a 34-year calendar period; total sperm counts had decreased from 443 to 300 million, 
without any concomitant change in semen volume (Splingart et al. 2012). Studies of university students 
from the southern part of Spain, born between 1974 and 1993, have also shown a decrease in both sperm 
concentration and total sperm count according to year of birth (Mendiola et al. 2013). 
In contrast to the studies described above, no trends among Swedish or Danish men from the general 
populations have been detected during the last 20 years. The Swedish study compared results from men 
investigated in 2000-2001 and in 2008-2010 and did not detect any difference between these two time 
points (Axelsson et al. 2011). Similarly, no changes were detected among Danish men in the period 
between 1996 and 2016 (Priskorn et al. 2018). However, in a comparison with a historical Danish cohort 
examined in 1940-1943, where sperm concentration was assessed by the same type of haemocytometer 
as used in the studies 1996 to 2016, it was shown that recent sperm counts were considerably lower. 
Sperm concentration had decreased from a median above 60 million/ml to 45 million/ml and total sperm 
count from more than 300 million to 143 million (Jorgensen et al. 2012). Vierula et al. (1996) reported 
that sperm count of Finnish men was high and unchanged. However, subsequent prospective cohort 
studies of young men from the general population from south-western Finland detected a decreasing 
sperm count among men born in the period 1979-1987 (Jorgensen et al. 2011). Due to the relatively short 
duration of the investigation and the age of the men it was not possible to determine whether these 
changes were best described according to year of birth or year of investigation (1996-2006). In a further 
investigation of new cohorts of Finnish men a continued decrease has recently been reported (Rodprasert 
et al. 2019). 
As stated above, the meta-analysis by Levine et al 2017 also reported findings for other populations in 
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Africa. This lack of significant findings from non-Western countries may partly be accounted for by limited 
statistical power and an absence of studies in unselected men in these non-Western countries prior to 
1985 (Levine et al. 2017). The main obstacle to using many historical publications is that many clinical 
studies on semen quality have dealt with selected groups of men like volunteers enrolled after 
advertisement, candidates for vasectomy or infertility patients, which hampers interpretation. Since 
publication of the Carlsen paper in 1992 there have numerous publications based on such populations 
reporting a downward trend in semen quality and it is beyond the scope of this paper to summarize all. 
Following the Levine publication in 2017, a meta-analysis of African data from 2017 concluded that there 
is “Evidence for decreasing sperm count in African population from 1965 to 2015” based on mixed 
populations from infertility clinics, laboratory studies and cohort studies (Sengupta et al 2017). This 
conclusion may be true but due to the potential selection biases the overall pattern in African men still 
remains unclear. A study of Indian fertile men detected a small downward trend in sperm concentration 
during a 37 years period and a steeper decline among infertile men. The selection bias for the infertile 
men was not described and the methods for assessment of semen parameters were not discussed 
(Mishra  et al, 2018). Studies from China investigating semen donor candidates where selection biases 
may be similar over the years have recently been published and described a downward trend for sperm 
concentrations and motility (Huang et al 2017; Wang et al 2017; Yuan et al 2018). A minor disadvantage is 
that assessments were done using Makler chambers which may lead to a lower precision in determination 
of semen variable (Christensen et al, 2005), but it provides some evidence that there may also have been 
a recent change in semen quality among men from various regions in China.
2.1.1.3 Conclusions about semen quality based on retrospective data. Although the retrospective 
approaches as described above are not ideal, this should not prevent us from trying to learn about the 
past. The existing analysis of historical data is the best that can be done, and the results clearly point to 
adverse temporal trends in semen quality and thereby in a broader sense in male reproductive health, at 
least among Western men. Interestingly, the association between year of birth and change in semen 
quality suggest that we should look for reasons among prenatal events affecting testicular development 
(Skakkebaek et al. 2001). This does not exclude the potential importance of postnatal events (Jorgensen 
et al. 2010; Nordkap et al. 2012). It is interesting to note that in most Western countries there have also 
been increases in incidence of testis cancer concomitantly with the decrease in semen quality 
(Skakkebaek et al. 2016). These increases also seem to be more strongly related to the year of birth than 
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who apparently also have the lowest sperm counts (Jorgensen et al. 2002). Imperfect as they are, these 
retrospective studies are strong enough to warn us about a current problem, and inspire us to establish 
well designed studies that can be used not only for longitudinal future measures but also to describe the 
current situation and potential reasons for declining semen quality.
2.1.2 Studies designed to detect between-country differences, current situation and future trends 
in semen quality
Inspired by these temporal trends in semen quality, cross-sectional, standardized and coordinated studies 
have been designed and undertaken to investigate semen quality of men from the general population 
(unselected regarding fertility status) in primarily western Europe, the US and Japan (Jorgensen et al. 
2002; Punab et al. 2002; Paasch et al. 2008; Mendiola et al. 2011; Fernandez et al. 2012; Iwamoto et al. 
2013). Similarly, standardized and coordinated studies of fertile men have also been undertaken 
(Jorgensen et al. 2001; Swan et al. 2003; Iwamoto, et al. 2013). When successfully carried out, such 
studies will contribute more conclusive information about the existence of differences in semen quality 
between countries than can be achieved by additional analyses of previously collected data. Furthermore, 
besides being able to describe the current situation, these data will serve as reference points for future 
follow-up studies to detect temporal changes and might also provide indications for the cause(s) of 
declining semen quality.
2.1.2.1 Selection bias is important to consider when studies are designed. A description of semen quality 
in a population must rely on results from examinations of a sample of men because it is not possible to 
examine the entire population. Therefore, since the aim must be to have a representative sample, an 
important question to consider is whether selection bias might influence outcome   (Eustache et al. 2004). 
Clearly, selection bias cannot completely be avoided and it is therefore essential that basic variables 
describing fertility status, health status, life-style factors and educational status are included and analysed 
in cross-sectional semen quality studies (Sanchez-Pozo, et al. 2013). 
2.1.2.2 Concern about fecundity of men from general populations. Standardized studies of men from the 
general populations of Western countries (see above) have shown statistically significant differences in 
average semen quality levels between men from different countries. From a biological point of view these 
between-country differences are less pronounced than the within country differences between men from 
the general population and men of proven fertility. When these studies are interpreted according to the 
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2001; Slama et al. 2002), rather than the artificial binary reference levels provided by the WHO (WHO 
2010; see above discussion), they might indicate that some men from general populations have semen 
quality that raises concern for their fecundity (Jorgensen et al. 2006; Skakkebaek et al. 2016; Smarr et al. 
2017). However, these predictions remain to be rigorously tested.
2.2 Semen quality is not only a marker of fecundity but also health
Recently, it was indicated that impaired semen quality/male infertility is associated with shorter life 
expectancy and increased long-term morbidity (Jensen et al. 2009; Eisenberg et al. 2014; Eisenberg et al. 
2015; Latif et al. 2017). The mechanisms underlying this association are not clearly understood, but 
reduced semen quality seems to be a marker that is linked to mortality in a dose-dependent manner and 
also to morbidity. For example, in a Danish population of men from infertile couples, men with a sperm 
concentration of 195–200 million/ml were, on average, hospitalized for the first time 7 years later than 
men with a sperm concentration of 0–5 million/ml (Latif et al. 2017). Impaired semen quality has been 
linked to a higher risk of testicular cancer in the years following infertility evaluation, both among Danish 
and US men (Peng et al. 2009), and some studies have suggested a link with development of prostate 
cancer, although this has not been confirmed by all studies (Giwercman et al. 2005; Walsh et al. 2010; 
Hanson et al. 2018). Other malignancies such as melanoma, bladder, thyroid and haematological cancers 
have also been more frequently observed among infertile men (Capogrosso et al. 2018; Hanson et al. 
2018). Significant associations between diabetes mellitus, metabolic disorders and male infertility were 
found and infertile men seem to have a higher risk of developing cardio-vascular diseases (Eisenberg et al. 
2014; Glazer et al. 2017). However, incidence of these diseases is not sufficient to explain the observed 
association between semen quality and mortality (Jensen et al. 2009). Although it is still not understood 
which diseases are associated with impaired semen quality, it seems that fertility and especially impaired 
semen quality might represent a universal biomarker of later health and survival. 
Infertility may hence serve as a marker of serious conditions later in life, but this association is in most 
cases not understood. It has been suggested that adverse lifestyle or environmental exposure during early 
fetal life, combined with a genetic or epigenetic predisposition, may lead to impairment of reproductive 
function and endocrine imbalance, which in turn may lead to cancer, osteoporosis, metabolic and 
cardiovascular disease. However, the association between fertility and health later in life may also be 
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to hamper fertility, but also the general health and, life expectancy is negatively affected (Jensen et al 
2004; Ramlau-Hansen et al 2007). However, despite the well-known adverse effects of such factors, they 
do not explain the overall associations between semen quality and morbidity (Latif et al 2018). Most men 
presenting with low semen quality have normal serum testosterone (T) levels (Andersson et al, 2004), and 
for most, the hormonal profile does not indicate immediate need of androgen replacement therapy, but 
rather suggests that the capacity of the testicular Leydig cells to produce testosterone is decreased. 
Recently, a compensated reduction in Leydig cell function – assessed as a decreased ratio between 
testosterone and luteinizing hormone (T/LH) - has been described even in men with semen quality well 
within the WHO normal reference ranges (Jørgensen et al, 2016). Most cases of testosterone deficiency 
develop through an initial stage of compensated Leydig cell failure (Tajar et al, 2012), and most likely, 
Leydig cell function decreases with age (Andersson et al 2007). However, it remains to be investigated 
whether men with subtle Leydig cell failure at young age will develop clinical symptoms of Leydig cell 
failure at a later stage. Thus, it is currently unresolved to which degree Leydig cell failure contributes as a 
causative factor to the associations between semen quality and health.
Men with fertility problems represent a relatively large and easily reachable part of the population 
showing excess mortality and morbidity risk. Therefore, men seeking help for infertility could be a good 
target for preventive measures aimed to achieve “healthy aging”. As recognition of this association has 
only recently emerged, the nature of preventive actions that might be taken to address the increased risk 
of long-term morbidity and mortality is yet to be established. A major and focused research effort is 
required to address this issue.
2.3 Exogenous influences on human male fertility 
The reasons for the poor and apparently declining quality of semen from men in many populations remain 
elusive. A wide range of internal and external environmental variables potentially affect semen quality, 
both by effects on reproductive function of the mature adult and by effects on development of the male 
reproductive system in utero.  A number of male reproductive disorders, including poor spermatogenesis, 
testicular cancer, hypospadias, and cryptorchidism have been found to be interrelated – both within 
individuals and at a population level. These factors, except isolated hypospadias, are associated with 
reduced fecundity. This has led to the proposal of a testicular dysgenesis syndrome (TDS) originating in 
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during a sensitive period in utero. This period has been identified in rodent models showing that normal 
development and later function of the male reproductive system is highly dependent on adequate 
androgen production during this sensitive window (Welsh et al. 2014). It is likely that a similar sensitive 
period occurs in humans at around gestational week 8-14, termed ‘the masculinization programming 
window’. It has been suggested that, in humans, development can be disturbed by genetic defects, 
epigenetic factors or adverse exposures, including maternal lifestyle, such as smoking during pregnancy, 
and exposure to environmental chemicals (Skakkebaek et al. 2016). Most likely, it is the cumulative effects 
of various low-dose exposures in our environment, rather than single exposures that contribute to the 
appearance of adverse effects in the male reproductive system. Animal studies provide evidence that 
manmade chemicals can disrupt the hormone dependent pathways responsible for fetal gonadal 
development, subsequently leading to TDS-like symptoms (Christiansen et al. 2009; Auharek et al. 2010; 
van den Driesche et al. 2012). Causal relationships are inherently difficult to establish in humans. 
Although the maximum potential for adult semen quality seems to be determined in utero, exposure to 
man-made chemicals in the environment and to other lifestyle-related stresses in the adult also influence 
semen quality. Additionally, several postnatal factors such as infections, surgical procedures and medical 
treatment might cause reduced semen quality in adulthood. 
A feature common to a number of these factors is excessive oxidative stress. Spermatozoa are known to 
generate reactive oxygen species (ROS), which are believed to play an important role in normal sperm 
functions such as capacitation (Aitken 2016; 2017). However, spermatozoa are particularly vulnerable to 
high levels of oxidative stress, which damage sperm structure (including damage to DNA) and impair 
function (Wright et al. 2014; Aitken 2017; Bisht & Dada, 2017; Bui et al. 2018). Excessive testicular levels 
of ROS are associated with varicocele, infection and inflammation (Agarwal et al. 2018) but also with 
lifestyle-linked influences such as tobacco and alcohol usage and obesity. Suffice it to say, testicular 
function seems to be sensitive to adverse events both pre-and postnatally. Some of the potentially more 
significant environmental stresses are briefly considered below.  
2.3.1 Environmental and lifestyle factors
2.3.1.1 Environmental influences and stresses. Air pollution is ubiquitous and the WHO estimates that 
~90% of people breathe air containing high levels of pollutants (https://www.who.int/airpollution/en/). 
Such pollution has been associated with a decrease in male fertility (Lafuente et al. 2016). Possible 
mechanisms include hormonal changes due to endocrine disruption (see below), oxidative stress, cell DNA 
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several pollutants impedes identification of the impact of individual specific pollutants (Carré et al. 2017) 
and may result in synergistic interaction. Effects on regulation of scrotal temperature, for instance the 
consequences of sedentary occupations, might also be important. Application of scrotal heat stress in 
fertile men significantly decreased sperm concentration compared with pre-exposure values, as well as 
the percentages of motile and progressively motile spermatozoa and the proportion of morphologically 
normal spermatozoa. After removal of the heat stress these parameters recovered to pre-exposure levels, 
the impact apparently being reversible (Zhang et al. 2015). 
2.3.1.2 Smoking. Although the mechanisms underlying the effects of tobacco smoking remain uncertain, 
cigarette smoking is acknowledged to affect semen quality (Kunzle et al. 2003; Ramlau-Hansen et al. 2007; 
Shrivastava et al. 2014). Li and colleagues, who undertook a large meta-analysis from 26 countries/regions 
(20 studies; 5865 participants), concluded that smoking causes a decline in semen quality in both fertile 
and infertile men (Li et al. 2011). Sub-group analyses indicated that effect size was higher in infertile men 
than in the general population and that deterioration of semen quality is ‘dose’-dependent, being more 
pronounced in moderate and heavy smokers (Sharma et al. 2016). A recent systematic review (16 studies; 
10,823 infertile male participants [5257 smokers and 5566 non-smokers]) reached similar conclusions 
(Bundhun et al. 2019). Oligozoospermia was significantly higher in smokers (RR: 1.29, 95% CI: 1.05-1.59) 
and normal sperm morphology was significantly lower in smokers (morphological defect RR: 2.44, 95% CI: 
0.99-3.89). However, there was no apparent effect on motility.
Several cross sectional studies show a significant effect of tobacco smoking on semen parameters and 
DNA fragmentation, as well as on gonadotrophin and testosterone levels (Al-Matubsi et al. 2011; Caserta 
et al. 2013; Anifandis et al. 2014; Jeng et al. 2014; Lotti et al. 2015). Paternal smoking also significantly 
negatively influences ART outcomes including in IVF and ICSI (Kovac et al. 2015). Amongst former 
smokers, every additional year following smoking cessation by the male partner reduced the risk of ART 
failure by 4%, particularly miscarriage (Vanegas et al. 2017). However, the data are not conclusive. For 
example, a prospective study on couples trying to conceive in the US found little association between 
current male smoking or passive smoking in either partner, with reduced fecundability (Wesselink et al. 
2019).  The Practice Committee of the ASRM, in their recent (2018) paper, concluded that ‘smoking has 
not yet conclusively been shown to affect male fertility’ (ASRM 2018). Surprisingly there is minimal data 
on the effect on semen parameters and fertility in men who have ceased smoking tobacco. Despite there 
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a recommendation of smoking cessation and minimizing exposure to tobacco smoke amongst couples 
who are trying to conceive.
Electronic cigarettes (e-cigarettes) typically contain propylene glycol (a tasteless, odourless, colorless 
alcohol used in antifreeze), vegetable glycerin, a variable amount of nicotine, food grade flavouring and 
water to generate an aerosol/vapor. Their use is commonly termed vaping, and is generally viewed to be 
less harmful than conventional smoking. Nonetheless, studies in animal models show detrimental effects 
on spermatogenesis and increase in oxidative stress (El Golli et al. 2016; Rahali et al. 2018) Although large 
scale human studies are not yet available, recent reports of severe pulmonary disease associated with the 
use of electronic cigarettes (vaping) has raised significant concern about their short and long-term safety 
(Hammond 2019). 
2.3.1.3 Caffeine. A recent systematic review of 28 papers (19,967 men in total) showed that semen 
parameters were not adversely affected by caffeine intake from coffee, tea and cocoa drinks in most 
studies. However,   a negative effect of cola-containing beverages and caffeine-containing soft drinks on 
semen volume, count and concentration was observed. Caffeine intake appeared to be associated with 
aneuploidy and occurrence of DNA strand breaks.  Coffee drinking in men was associated with prolonged 
time to pregnancy in some, but not all, studies (Ricci et al. 2017).
2.3.1.4 Alcohol. Given that a significant number of men regularly drink alcohol it is perhaps surprising that 
the impact of alcohol consumption on male fertility is not well understood. Overall alcohol consumption 
has been associated with lower semen volume but has a variable, and probably dose-dependent, impact 
on semen parameters (Li et al. 2011). Habitual alcohol consumption is associated with reduced semen 
quality and changes in reproductive hormones (Jensen et al. 2014). Similarly, semen volume, sperm count, 
motility, and number of morphologically normal spermatozoa were all significantly decreased in a study of 
those with heavy and chronic alcohol consumption (Muthusami & Chinnaswamy 2005). In agreement with 
this, a recent meta-analysis indicates an effect of alcohol consumption on semen volume and sperm 
morphology. However, the review found no evidence for negative effects of occasional alcohol intake 
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2.3.1.5 Psychological stress. Psychological stress adversely affects testicular function such that stressful 
life events may be associated with decreased semen quality, an effect that might be primarily due to 
suppression of testosterone by raised corticosteroid levels (Nargund 2015). Gollenberg et al. (2010) found 
that men reporting two or more recent stressful life events had an increased risk of having sperm 
concentration, motility, and morphology below ‘normal’ WHO thresholds. A meta-analysis of 57 cross-
sectional studies (29,914 participants) indicated that psychological stress could lower sperm 
concentration and progressive motility, and increase the fraction of abnormal spermatozoa   (Li et al. 
2011). In a later cross-sectional study of 1,215 Danish men, those with self-reported stress scores above 
an intermediate stress level had poorer semen quality and those with the highest stress levels had 
significantly lower sperm concentration, total sperm count, and seminal volume compared to those with 
intermediate stress levels (Nordkap et al. 2016). An association has also been reported between 
stress/depression and semen quality for those experiencing fertility issues (Arya & Dibb 2016). 
Antidepressant drugs used to treat depression, anxiety disorders, chronic pain and a variety of other 
conditions have negative effects on sexual function and semen quality (Drobnis and Nangia 2017). 
Nonetheless, non-pharmacological management of stress for infertile men, including cognitive behaviour 
therapy, psychotherapy and fertility counselling and support, may be beneficial (Frederiksen et al. 2015). 
2.3.1.6 Sleep. Sleep disturbance is common and its prevalence is increasing (Palnitkar et al. 2018). The 
influence of sleep (or sleep disturbance) on a range of physiological processes is well recognized and 
might contribute to male infertility (Jensen et al. 2013). Testosterone secretion follows a diurnal pattern, 
with rise in testosterone levels coinciding with rapid eye movement (REM) sleep rather than with changes 
in levels of melatonin (Luboshitzky et al. 2001). Prolactin levels are also sleep-dependent, with an increase 
in prolactin secretion during sleep. Sleep duration is associated with testis size in healthy young men 
(Zhang et al. 2018) and obstructive sleep apnea, characterized by repetitive nocturnal hypoxia, is 
associated with increased levels of oxidative stress independent of obesity or reproductive hormone 
profile (Eisele et al. 2015). Combined or interacting effects of stress, depression and poor sleep on semen 
parameters may be significant (Janevic et al. 2014; Nordkap et al. 2016; Radwan et al. 2016; Wdowiak et 
al. 2017). 
2.3.1.7 Dietary intake and obesity. Diet, both in terms of nutritional balance and (in combination with 
inadequate levels of activity) excessive calorific intake leading to obesity, affect semen quality and male 
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beverages are associated with poor semen quality and lower fecundity rates (Salas-Huetos et al. 2017). 
Intake of full-fat dairy was inversely related to sperm motility and morphology among physically active 
men. Cheese, rather than overall dietary patterns, seemed to be primarily responsible for this effect, but 
the mechanism linking dairy food intake to lower sperm motility and morphology was not clear (Afeiche 
et al. 2013). However, Jensen et al. (2013) reported lower sperm concentration and total sperm count 
were dose-dependently associated with high dietary intake of saturated fat among 701 young Danish men 
from the general population. The authors expressed concern that changes in diet over the past decades 
might in part be responsible for the high frequency of sub-normal sperm counts reported. 
The current increase in the incidence of obesity is also of concern with respect to male reproductive 
health. A meta-analysis of men from both the general population and from infertile couples showed the 
increased prevalence of azoospermia or oligozoospermia in men who were overweight or obese 
(Sermondade et al. 2013). In a population-based prospective cohort of 501 couples, ejaculate volume 
showed an inverse linear relationship to body mass index and waist circumference. Similarly, total sperm 
count showed a significant negative linear association with waist circumference. The authors concluded 
that ‘male infertility is a proxy of the overall male health status’ (Eisenberg et al. 2014).  Paternal obesity 
negatively affects both male fertility and assisted reproduction outcomes (Campbell et al. 2015). A recent, 
large-scale study (4,440 men) showed statistically significant relationships between obesity and semen 
analysis parameters (Bieniek, et al. 2016). However, the effect of significant weight loss on semen analysis 
parameters is uncertain, and reports are conflicting, reporting either significant improvement (Hakonsen 
et al. 2011; Faure et al. 2014; El Bardisi et al. 2016; Kahn & Brannigan 2017; Samavat et al. 2018), no 
change (Legro et al. 2015), or even deterioration (Lazaros et al. 2012; Sermondade et al. 2012). It is 
certainly worth noting that weight loss intervention is complex, and is likely to underlie the heterogeneity 
reported in these studies. It is also difficult to know whether observed improvements in semen quality are 
related to weight loss per se or to other, confounding factors such as change in diet, increase in exercise 
and improved metabolic profiles. 
2.3.1.8 Endocrine disruptors and male fertility.  Endocrine disrupting chemicals (EDCs) are “exogenous 
substances, which have the ability to alter function(s) of the endocrine system and consequently cause 
adverse health effects in an intact organism, or its progeny, or (sub)populations” (EAA, 2012; Bergman et 
al. 2013; Rodprasert et al. 2019). Known EDCs are a diverse range of small, often lipophilic, molecules that 
fall within many different and widely used categories of chemicals, e.g. pesticides, pharmaceuticals, and 









This article is protected by copyright. All rights reserved
environment such that humans are at high risk of exposure (Kabir et al. 2015).  Even those that are rapidly 
metabolized, such as phthalates and bisphenol A, can be present in human tissues at significant levels due 
to continuous exposure. Many EDCs have been shown to interfere with the activity of sex hormone 
steroids and thereby might affect functioning of the male reproductive system, e.g. by acting as agonists 
or antagonists of the hormone receptors, by affecting the production or metabolism of endogenous sex 
steroids, or by modulating hormone signaling events in other ways (EEA 2012; Bergman et al. 2013; Gore 
et al. 2015). 
Toxicological studies on animals indicate that some EDCs may indeed impair the development and 
functioning of the male reproductive system and thus might underlie, at least in part, the decline in 
human semen quality that has been observed in western populations (Sharpe & Skakkebaek 1993; Levine 
et al. 2017; see section 2.1). Sex differentiation of the male fetus seems to be particularly vulnerable to 
disruption of sex hormone function (Skakkebaek et al. 2001; Juul et al. 2014; Skakkebaek et al. 2016). 
However, attempts to establish an association between levels of EDCs and semen quality in humans have 
proved difficult (Bliatka et al. 2017). Wang and colleagues (Wang et al. 2016) carried out a meta-analysis 
on association between EDC exposure and semen quality. Their analysis indicated that exposure to 
phthalates and organochlorine insecticides e.g. dichlorodiphenyl trichloroethane [DDT] might be 
associated with reduced semen quality. These studies focused on associations between adult exposure 
and semen quality, while toxicological data indicate that fetal EDC exposure, especially during sex 
differentiation, could have a lasting impact on adult reproductive function.   Bonde et al. (2016), 
undertook a large meta-analysis (33 papers; 28 study populations) and investigated association between 
pre- and perinatal EDC levels and four aspects of male reproductive function: cryptorchidism, 
hypospadias, low sperm counts and testicular cancer. A significant association of prenatal and postnatal 
exposure to p,p′-DDE (p,p′-dichlorodiphenyldichloroethylene; a persistent metabolite of DDT) with the 
incidence of cryptorchidism, hypospadias or testicular cancer was detected (13 studies). However, the 
overall odds ratio for the analysis (all exposures and outcomes) was 1.11 (95% CI 0.91–1.35). Di Nisio & 
Foresta (2019) reviewed the data related to the effects of EDCs on male health and fertility, concentrating 
on phthalates, bisphenol A, organophosphate insecticides, perfluoroalkyls and cadmium. They concluded 
that ‘Despite promising discoveries, a causal relationship between reproductive disorders and exposure to 
specific toxicants has yet to be established.’ Bliatka et al. (2017), addressing the question of why clear 
evidence for the effects of EDCs on human male reproduction is still lacking, concluded that well-designed 
studies (case–control or cohort type) will be required. The timing of exposure in relation to relevant 
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shown that exposures to combinations of EDCs, even if their initial site/mode of action varies, have effects 
that are additive or synergistic (Christiansen et al. 2009; Conley et al. 2018). Simple dose effect 
relationships of a single chemical may be masked by the concurrent exposure to other EDCs. Future 
studies should consider such combinations. 
2.3.1.9 Anabolic-androgenic steroids Anabolic-androgenic steroids (AAS) are non-prescription synthetic 
testosterone-like substances misused by athletes and bodybuilders  (Kanayama & Pope 2018). At least 30 
different AAS exist, including testosterone and its precursors (androstenedione, dehydroepiandrosterone; 
DHEA), 17α-alkyl-derivates (oral preparations, such as stanozolol, oxandrolone, methyltestosterone) and 
17β-ester-derivates (parenteral preparations, including nandrolone and testosterone esters) (Duca et al.  
.2019). They increase lean muscle mass in conjunction with weight training and are also used to improve 
strength and physical performance as well as exercise recovery. The vast majority of people who misuse 
steroids are male recreational power athletes in their 20s or 30s, with estimated 6.4% global lifetime 
prevalence rate (Sagoe et al. 2014). 
Simplistically, AAS use results in hypogonadotropic hypogonadism, resulting in decreased secretion of 
endogenous testosterone as well as oligozoospermia or azoospermia and testicular atrophy (Duca et al. 
2019). The effects are usually reversible (El Osta et al., 2016). However, it is notable that AAS users are 
more likely to take multiple supplements, including protein powders and creatine, other appearance and 
performance enhancing drugs (APED) and medication for erectile dysfunction (Ip et al 2011) as well as 
recreational drugs (Kanayama, Pope 2012;.
2.3.1.10 Lubricants Although commonly available, studies have demonstrated most vaginal lubricants to 
be detrimental to spermatozoa in vitro (Mowat et al. 2014; Sandhu, et al. 2014; Wilson et al. 2017). Their 
impact on fertility and natural conception is unclear at best (Steiner et al. 2012), however the use of 
vaginal lubricants during intercourse should not be recommended for couples with infertility unless they 
are able to be deemed ‘Sperm safe’ (Mortimer et al. 2013; Mackenzie & Gellatly 2019). 
2.3.2 Occupational risks to male fertility. 
2.3.2.1 Effects of occupational exposure. The effects on male fertility of occupational risks are poorly 
explored in clinical e.g. NICE (NICE 2013) or strategic guidelines (Barratt et al. 2017) yet there is a long 









This article is protected by copyright. All rights reserved
examining semen quality as a surrogate marker of fertility of men in different occupations. Unfortunately 
there is no consistency of assessment approach – for example, sperm concentration, motility, motile 
sperm concentration and morphology have all been used as markers of fertility and data interpreted in 
different ways. There have also been studies examining the relationship between occupation and sperm 
DNA quality, but these are relatively rare and are similarly complicated by the array of different tests used 
(see section 1.3).
Occupational-related risks to fertility vary widely but can be simply classified into five types: Physical 
agents (e.g. noise, vibration, radiation, heat); Chemical agents (e.g. fumes, gasses, aerosols and mists); 
Biological agents (e.g. bacteria, fungi, insects, viruses); Psychosocial (e.g. stress, unsociable hours); 
Ergonomical (e.g. manual handling, repetitive movement, working in confined spaces). Whilst there are 
no a priori hypotheses to link many of these risks to poor male fertility, most studies have only 
concentrated on the effects of chemical exposures. The landmark study, linking chemical exposure with 
male infertility, published more than 40 years ago, was the identification of 1,2-dibromo-3-chloropropane 
(DBCP) exposure as the cause of infertility in workers at a pesticide factory in California in 1977 (Whorton 
et al. 1977; Whorton & Foliart 1988). However, progress in identifying other chemical risks to male 
fertility was slow and by the early 1980’s only five chemical risks had been identified: carbon disulphide, 
inorganic lead, 1,2-dibromo-3-chloropropane (as above), ethylene dibromide (with DBCP); and toluene 
diamine (Wyrobek 1983). Subsequently, the risks of chemicals such as perchloroethylene, oxychlordane 
and benzene were also identified (see Schrader and Marlow, 2014).
Perhaps the largest study to examine the relationship between occupation and semen quality was the 
Chemicals and Pregnancy Study (CHAPS-UK) which took place in the UK and examined the job history of 
nearly 2,500 men attending 14 fertility clinics between 1999 and 2002. Analysis of the data from this 
study showed that; (i) moderate and high occupational exposure to glycol ether was related to low motile 
sperm count (Cherry et al. 2008), (ii) poor sperm morphology was related to self-reported lifetime 
exposure to lead (Cherry et al. 2014) and (iii) self-reported use of paint stripper and lead, but not glycol 
ether, were significantly related to both low motile sperm count and poor sperm morphology (Cherry et 
al. 2014). Interestingly, there was an increased risk of low motile sperm count (Povey et al. 2012) but not 
poor morphology (Pacey et al. 2014) in men who were not working, suggesting a possible overall benefit 
to fertility of being in employment. Whilst studies using measures of semen quality measures are 
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TTP was increased following male partner exposure to lead and pesticides, with some evidence of harm 
following exposure to organic solvents or mixtures of oil products / chemicals (Snijder et al. 2012). The 
overall consensus from studies seems to be that from a public health perspective there are relatively few 
occupational risks to the fertility of adult men in Western (post-industrial) societies (Bonde 2014), though 
this conclusion remains tentative as  large, comprehensive, robust studies using multivariate models 
remains to completed. It is also very important to point out that, in comparison, little is known about the 
risks to adult men in low and middle income countries.
2.3.2.2. Mitigation of occupational risk. A hierarchy of control measures to mitigate occupational risks  has 
been developed.  These measures include hazard limitation (remove the hazard from the workplace), 
substitution (replace the hazard with an alternative procedure/substance that is believed to mitigate the 
risk), engineering (isolate workers from the hazard), administrative (change working practices to minimize 
exposure) and Personal Protective Equipment (protect the worker by requiring that protective clothing or 
equipment is worn/used). There are relatively few documented examples of how these control measures 
have been used to mitigate occupational threats to male fertility. In the case of workers exposed to 1,2-
dibromo-3-chloropropane (see above), whilst the first reports of effects on  male fertility were published 
in 1977, it was not fully banned for agricultural use until 1985, and in 2009 it was still available in the 
supply chain. Advice to doctors about the clinical management of men working in high risk occupations is 
generally poor. For example, National Institute for Health and Clinical Excellence (NICE 2013) advises that 
“some occupations involve exposure to hazards that can reduce male or female fertility and therefore a 
specific enquiry about occupation should be made to people who are concerned about their fertility and 
appropriate advice should be offered.” However, there is no guidance about what the “appropriate 
advice” should be.
3. Workshop Session 3- Clinical Management of Male Infertility
3.1 Genetic and epigenetic aspects of male infertility 
Male infertility is a multifactorial condition in which the occurrence of known genetic factors is relatively 
frequent (e.g. Klinefelter syndrome). The clinical significance of identifying genetic factors responsible for 
male infertility is important in the era of IVF and more particularly ICSI. Patients affected by a severe male 
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the couple is an important requirement prior to IVF and in some instances includes testing of the female 
partner (for instance partner affected by congenital absence of vas deferens [CBAVD] due to cystic fibrosis 
transmembrane conductance regulator [CFTR] mutations).
3.1.1 Genetic testing. 
In azoospermic men the risk for being a carrier of known genetic anomalies is high (20-25%), with the 
frequency progressively decreasing with increasing sperm output (Punab et al. 2017; Tournaye et al. 2017; 
Tournaye et al. 2017b; Krausz et al. 2018; Krausz & Riera-Escamilla 2018). Genetic testing is therefore an 
essential tool for clinical decision-making. Identification of a causative genetic factor might allow 
prediction of outcome of testicular sperm retrieval, with the potential to avoid unnecessary surgical or 
medical treatments. It might also indicate the need for   sperm cryopreservation in young adulthood if a 
progressive decrease of sperm production is predicted, and/or highlight concerns regarding the patient’s 
general health. Routine molecular genetic testing in men with quantitative impairment of 
spermatogenesis is currently limited to karyotype analysis and azoospermia factor (AZF) deletion 
screening. Chromosomal anomalies are the most frequent genetic factors in severe oligo/azoospermia. 
These tests are indicated in all patients affected by moderate or severe oligozoospermia and azoospermia 
(Krausz et al. 2014; Krausz et al. 2018). Testing for AZF deletions has both diagnostic and prognostic value. 
Complete deletions of the AZFa and AZFb regions causes azoospermia with virtually no chance of sperm 
recovery through testis biopsy. It is important to note that the definition of the extension of AZFb deletion 
with a specific set of markers is necessary for prognostic purposes. Moreover, AZF deletions will be 
transmitted to the male offspring so clearly informed, appropriate counselling of the couple is vital 
(Krausz et al. 2014). 
3.1.2 Mutation screening. 
Given the risk of transmitting genetic disorders the diagnosis of known and the discovery of novel genetic 
factors in idiopathic infertility is of utmost clinical importance. Screening for mutations in candidate genes 
for specific male infertility phenotypes is not a routine practice but they are becoming increasingly 
available in a number of laboratories. Next-generation sequencing (NGS) based panels are available for 
the following diseases: congenital hypogonadotropic hypogonadism (cHH), partial or mild androgen 
insensitivity syndrome, CBAVD and monomorphic forms of teratozoospermia and asthenozoospermia 
(Tournaye et al. 2017; Tournaye et al. 2017b; Krausz et al. 2018; Krausz & Riera-Escamilla 2018). Genome 
Wide Association Studies (GWAS) are based on high throughput analyses (single nucleotide polymorphism 
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relevant data to our knowledge, strongly suggesting that common or low- frequency polymorphisms do 
not have a major role from a diagnostic perspective (Krausz et al. 2015). Only high-resolution X 
chromosome-specific a-CGH studies were able to identify clinically relevant deletions, the TEX11 
intragenic deletion and CNV67 (for reviews see (Ropke & Tuttelmann 2017; Krausz et al. 2018; Krausz & 
Riera-Escamilla 2018). Whole exome sequencing has not proved to be a successful diagnostic tool in 
infertile patients with consanguineous parents or in familial cases of non-obstructive azoospermia (NOA), 
oligoasthenoteratozoospermia (OAT), monomorphic teratozoospermia or asthenozoospermia  (Coutton et 
al. 2015; Krausz et al. 2018; Krausz & Riera-Escamilla 2018).
3.1.3 Epigenetic effects. 
In addition to the effects of genetic mutations, the importance of epigenetic factors in the determination 
of semen quality is now recognized. Epigenetic alterations such as unequal protamine ratios, aberrant 
DNA methylation, histone modifications and  miRNA profile have been described in association with 
decreased semen quality, decreased fertilization ability, DNA damage and reduced IVF success and 
embryo quality (Jenkins et al. 2017). Aberrant methylation in imprinted genes could be responsible for 
imprinting diseases (Angelman and Beckwith-Wiedemann syndrome) in the offspring but this issue is still 
hotly debated. Diagnostic application of the acquired knowledge is still missing (methodological issues, 
lack of large studies; (Klaver & Gromoll 2014)) and the clinical significance of these observations is yet to 
be established.  Notwithstanding this, there is, at least in the animal literature, a rapidly growing 
awareness of the impact of paternal epigenetic transmission to the next generation (Kaneshiro et al. 
2019; Monk et al. 2019). The underlying mechanisms are still unclear and the evidence in humans remains 
sparse, but this is an area of significant concern and further research is clearly warranted.
3.1.4 Future directions
Despite efforts and progress in understanding genetic defects underlying male-factor infertility, large 
proportions of NOA and OAT cases are still defined as idiopathic. Exome/genome analysis is promising but 
the diagnostic role of these approaches in infertile patients with unrelated parents (the majority are 
idiopathic sporadic NOA or OAT) is still under evaluation. A comprehensive collection of functionally 
validated datasets and the development of new precise function predictor algorithms is needed to enable 
clinical interpretation of the observed variants (especially heterozygous autosomal variants) identified in 
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consortia such as the GEMINI consortium (https://gemini.conradlab.org/) and the International Male 
Infertility Genomics Consortium (http://www.imigc.org/).
An emerging clinical issue is the higher rate of morbidity (including cancer) and lower life expectancy in 
infertile men (see section 2.1.3). The significantly higher deletion load in infertile men compared to 
normozoospermic men indicates a higher propensity to genomic instability in a subset of infertile men 
(Ropke & Tuttelmann 2017; Krausz & Riera-Escamilla 2018). Furthermore, defects in mismatch repair 
proteins may lead to both spermatogenic failure and predisposition to cancer development (Krausz et al. 
2019). This implies that infertile patients carrying specific genetic alterations need a life-long follow up to 
prevent or diagnose co-morbidities at an early stage (see above).
In addition to the effects of genetic mutations and epigenetic factors on male fertility, the role of gene-
environmental interaction in male infertility is largely unexplored.  Data on endocrine disrupters (see 
section 2.2.1.8 above) are still controversial and the analysis of such an interaction has been performed 
mainly in animal models. The study of such effects in humans is highly challenging, but in the context of 
the apparent ongoing decline in semen quality (see section 2.1.1 above), this must be urgently explored. 
3.2 Hormonal treatment of male infertility
Despite progress in diagnosing the causes of infertility, in many cases, the etiology remains unknown, 
termed ‘idiopathic infertility’ (Krausz 2011).  In this category of patients, a number of empirical 
treatments have been proposed, including hormonal therapies, with controversial results (Tournaye et al. 
2017; Khourdaji et al. 2018).
3.2.1 Treatment of hypogonadotropic hypogonadism. 
3.2.1.1 Treatments for Hypogonadotropic hypogonadism. Hypogonadotropic hypogonadism (HHG) is one 
of the few causes of male infertility where medical hormonal therapy is clearly effective. HHG is 
characterized by hypothalamic or pituitary dysfunction; low serum gonadotropin levels, and reduced 
testicular function that presents clinically with testosterone deficiency, azoospermia, oligozoospermia and 
or small testicular volume. Clinical benefits have been reported for treatments with human chorionic 
gonadotropin (hCG) alone, or in combination with  urinary follicle-stimulating hormone (FSH; Liu, et al. 
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most physiological approach for replacing hormones in HHG but, since it acts by inducing release of 
gonadotropic hormones from the anterior pituitary, it is a rational choice only for subjects with normal 
pituitary function (Delemarre-Van de Waal & Odink, 1993; Pitteloud et al. 2005; Sykiotis et al. 2010). Both 
pulsatile infusion of GnRH and combined gonadotropin and human menopausal gonadotropin (hCG/hMG) 
can effectively induce spermatogenesis in men with HHG, although it is not known which treatment 
regimen might be best   (Mao et al. 2017). Recombinant hCG (Liu et al. 2009) and LH (Cailleux-Bounacer et 
al. 2008) are also available, but their efficacy remains unknown. GnRH therapy is reported to induce a 
pregnancy rate of up to 80%, with a time to achieve pregnancy similar to combined gonadotropin therapy 
(Buchter et al. 1998). Worldwide, GnRH is less likely to be used than hCG alone or in combination with 
FSH due to cost, inconvenience   and ineffectiveness in cases of panhypopituitarism or GnRH receptor 
mutation. A recent retrospective study (Mao et al. 2017) found that pulsatile GnRH therapy was 
associated with earlier spermatogenesis and larger testicular size compared to combined gonadotropin 
therapy. However, prospective randomized studies are required.  
 3.2.1.2. Use of FSH pre-treatment. The most important determinant of a successful response to 
gonadotropin therapy is baseline testis volume, higher volume being associated with a faster achievement 
of spermatogenesis (Buchter et al. 1998; Ishikawa et al. 2007). The optimal regimen in patients with 
severe cases (testicular volume <4 ml) is unknown. Fertility outcome is generally poorer in patients with 
signs of absent mini-puberty (Pitteloud et al. 2005; Liu et al. 2009). Pretreatment with recombinant FSH 
prior to GnRH therapy (to mimic mini-puberty) may improve fertility outcomes and can be considered as 
an alternative to GnRH alone (Dwyer et al. 2013). Data from animal studies indicate that a pre-pubertal 
‘window’ occurs in the immature testis during which FSH can induce Sertoli cell proliferation (Majumdar 
et al. 2012). Alhough use of FSH-pre-treatment did increase sperm count and rate of conception 
compared to treatment with GnRH alone, the difference did not reach statistical significance and larger 
prospective studies are needed.  
Recombinant human FSH (rhFSH) preparations seem to be as efficacious as the urinary derivatives (Krausz 
2011), with no difference in terms of stimulation of spermatogenesis or sperm concentration (Rastrelli et 
al. 2014). For better compliance, long-acting FSH formulations have been proposed (i.e. corifollitropin 
alfa) in place of rhFSH (Nieschlag et al. 2017), which may improve patient satisfaction and compliance. 
Results have been encouraging, suggesting that, for men suffering from HHG who desire fertility, long 
acting corifollitropin alfa can effectively and safely replace rhFSH in the treatment regimen. However, 
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been thoroughly conducted. Moreover, there are no randomized controlled studies comparing 
gonadotropin treatment regimens (Rastrelli et al. 2014). The low prevalence of idiopathic HHG and other 
forms of HHG presents a significant obstacle to the organization of such trials and placebo-controlled 
studies, resulting in absence of pubertal development in the control group, would be ethically 
unjustifiable.
 
After completion of therapy for infertility, most men with HHG will benefit from lifelong hormonal 
therapy (Mao et al. 2015). This is usually achieved by switching to testosterone replacement. This will 
result in a return to clinical infertility, but it is more cost-effective than gonadotropin replacement therapy 
and its use for long durations has been better characterized (Practice Committee of the American Society 
for Reproductive Medicine 2018). The best therapeutic choice needs to be elucidated for these vulnerable 
patients.
3.2.2 Hormonal treatment of idiopathic infertility 
The use of empirical medical therapies remains inconclusive and disappointing for men with idiopathic 
infertility. Estrogen receptor antagonists (e.g. Tamoxifen, clomiphene) may be applied on the basis that a 
non-invasive treatment with limited side effects can be effective (Colpi et al. 2018). Aromatase inhibitors 
have also been recommended for men with impaired sperm parameters and a low testosterone/estrogen 
ratio but the data are limited (Jung & Seo 2014). RhFSH or purified human FSH application to idiopathic 
male infertility is more controversial (Colpi et al. 2018). Further evidence for the efficacy of and selection 
criteria for medical treatment of oligoasthenozooteratozoospermia (OAT)  is required (Colpi et al. 2018). 
The lack of clear consensus on the management of these conditions reflects our poor understanding of 
underlying aetiology. 
Finally, impaired semen quality may be associated with hypogonadism (Colpi et al. 2018). Treatment with 
exogenous testosterone is sometimes given but is not appropriate.  Typical therapeutic doses of 
testosterone act as negative feedback on the hypothalamic-pituitary-gonadal axis, inhibiting secretion of 
LH and greatly reducing endogenous testosterone production (Mortimer et al. 2013; Colpi et al. 2018). If 
hypogonadism coincides with fertility issues, hCG treatment, which stimulates testosterone production of 
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3.3 Non-hormonal medical treatment of male infertility
In addition to the hormonal approaches outlined above, non-hormonal treatments have a role in clinical 
management of male infertility. Such treatments may effectively remove a reversible cause of infertility, 
or can result in sufficient amelioration of the environment in which spermatozoa are produced and 
mature, that semen parameters are significantly improved. In cases such as idiopathic OAT or infertile 
patients without identifiable cause(s), non-hormonal treatments are frequently used, such as anti-
inflammatory drugs and treatment with or enrichment of dietary antioxidant compounds and vitamins. 
Currently the scientific evidence for the effectiveness of such empirical treatment is relatively poor and 
further studies are required to clarify the role of this approach (Showell et al. 2014; Smits et al. 2019). 
However, three characterized, often co-existing conditions that interfere with reproductive function 
(oxidative stress, inflammation, infection) may be responsive to focused (non-empirical) non-hormonal 
treatments (Calogero et al. 2017). These are the use of antioxidants (to ameliorate the damaging effects 
of excessive oxidative stress) and treatment with anti-inflammatory and antibiotic drugs. 
3.3.1 Antioxidants
There is a significant body of evidence to support the role of oxidative stress in sperm dysfunction (Aitken 
2016) and thus antioxidant therapy appears a logical approach. A plethora of different products has been 
used clinically and there are many, readily available, putative fertility enhancing supplements on the 
market. However, critical evidence to support their use is absent (Barratt 2018; Martins da Silva 2019).  
A systematic review and meta-analysis of effect of nutrients and dietary supplements (Salas-Huetos et al. 
2018) found that sperm concentration was increased by selenium, zinc, omega-3 fatty acids and 
coenzyme Q10 (CoQ10). Sperm counts were increased by omega-3 and CoQ10 supplementation. 
Selenium, zinc, omega-3, CoQ10 and carnitines increased sperm total motility, whereas sperm progressive 
motility was increased only after supplementation with carnitines. Finally, sperm morphology was 
enhanced by selenium, omega-3, CoQ10 and carnitine supplementation. Importantly however   male 
fertility was not assessed and the authors conclude that the results should be interpreted cautiously due 
to the limited sample size of the meta-analyzed studies and the considerable observed inter-study 
heterogeneity (Salas-Huetos et al. 2018). 
A recent Cochrane review, which examined the role of supplementary oral antioxidants in sub fertile men 
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for male subfertility (OR 1.79, 95% CI 1.20 to 2.67). However, the data were limited, being based on 7 
randomized clinical trials, comprising 750 men and only 124 live births. A further 11 trials (786 men) 
indicate that antioxidants may increase clinical pregnancy rate (OR 2.97, 95% CI 1.91 to 4.63). However, 
when studies at significant risk of bias were removed from the analysis there was no evidence of 
increased live birth rate. Overall, the evidence from these trials is low quality and the authors conclude 
that the data are inconclusive. Whilst a healthy diet is certainly conducive to a healthy body and hence a 
potential association with gamete quality, we are a long way from concluding that supplementation of the 
diet is clearly beneficial for male fertility. Large randomized placebo-controlled trials are required to 
address these questions (Barratt 2018).   
3.3.2 Anti-inflammatory drugs
3.3.2.1. Non-steroidal anti-inflammatory drugs.  Non-steroidal anti-inflammatory drugs (NSAID) may have 
an impact on semen parameters. Some studies reported deleterious effect of salicylates and profens 
(Porat-Soldin & Soldin 1992; Vargas et al. 2011; Roodbari et al. 2015) on semen parameters. On the other 
hand, data on the effect of cox-2 inhibitors and sulfonanilides indicate positive effects (Canale et al. 1993; 
Gambera et al. 2007). Overall, it appears that, though NSAIDs might be useful for relief of symptoms in 
treating acute forms of male accessory gland inflammation, they should (if possible) be avoided for 
chronic usage. More studies are required to examine the positive effects of cox inhibitors on patients with 
“idiopathic” leukocytospermia (Calogero et al. 2017). 
3.3.2.2 Steroidal anti-inflammatory drugs. Steroidal anti-inflammatory drugs, such as glucocorticoids, have 
been used for the treatment of men with antisperm antibodies (ASA) but the results from RCTs have been 
mixed. Three showed no significant difference in pregnancy rates (Haas & Manganiello 1987; Bals-Pratsch 
et al. 1992; Lahteenmaki et al. 1995). Two other RCTs showed a significant increase in pregnancy rate 
(Hendry et al. 1990; Omu, et al. 1996) and a more recent RCT (Taiyeb et al. 2017) on 241 men found that 
prednisolone treatment improved sperm motility/progressive motility and pregnancy rate in IVF (but not 
ICSI). However, before use, it is important to establish potential side effects of these treatments. 
3.3.3 Antibiotics 
Where sub/infertility is associated with a clear bacterial infection (male accessory gland infection (MAGI) 
the use of antibiotics in treatment is well established. The choice of antibiotic prescribed is based upon 
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Use of antibiotic treatment in men with leukocytospermia is much more contentious, particularly given 
global concerns of antimicrobial resistance (https://www.who.int/antimicrobial-resistance/global-action-
plan/en/). . A systematic review (Jung et al. 2016) identified only 11   RCTs concerning treatment of 
leukocytospermia performed over two decades (1984 – 2003).t  The studiesused variable methodology  
for leucocyte assessment   and dose/duration of antibiotic intervention (quinolones, tetracyclines, 
macrolides, sulfonamides, and penicillins)  . Three of the trials showed statistically significant 
improvement of sperm concentration and/or motility between the treated and untreated groups (Baker 
et al. 1984; Comhaire et al. 1986; Vicari 2000), but in three other studies no statistically significant 
differences were reported (Yanushpolsky et al. 1995; Erel et al. 1997; Krisp et al. 2003). One trial reported 
significant improvement of sperm motility and morphology (Lewis-Jones et al. 1996). Antibiotics resulted 
in a statistically significant resolution of leukocytospermia in 5/8 trials (Comhaire et al. 1986; Branigan & 
Muller 1994; Yamamoto et al. 1995; Vicari 2000).  The cure rate was reported in only 3/11 trials 
(Comhaire et al. 1986; Vicari 2000; Krisp et al. 2003) but all studies showed a statistically significant 
decrease in the number of seminal bacteria. Four of the studies (Comhaire et al. 1986; Branigan & Muller 
1994; Yamamoto et al., 1995;  Vicari 2000) reported the pregnancy rate after treatment but only one 
(Vicari 2000) showed a statistically significant improvement in the treated group compared with the 
untreated group. Overall number of pregnancies was higher in the treatment groups. A complication for 
the use of antibiotics in treatment of male fertility is that there is evidence for adverse effects of 
antimicrobials on testis and sperm function. In summary, there are limited data available and there is a 
‘substantial need for well-designed clinical trials in this area‘ (Khaki, 2015; Samplaski and Nangia, 2015; 
Drobnis and Nangia, 2017). 
4. Workshop session 4 - The Over-Use of ICSI 
There is absolutely no question that ICSI treatment for male factor infertility has transformed 
reproductive medicine and offers  a clear option for treatment. However, there has been a significant 
trend to use ICSI for non-male factor cases. For example, according to data from US National Assisted 
Technology Surveillance system (1996-2012),  65% of fresh cycles used ICSI yet only ~36% were reported 
male factor infertility (Boulet et al. 2015).  Hans Evers highlighted the overuse of ICSI in a specific editorial 
entitled ‘Santa Claus in the fertility clinic’ (Evers 2016). Data from ICMART (International Committee for 
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ICSI:IVF ratio from 1.4 in Asia to 60.3 in the Middle East. A recent ICMART report (Adamson et al. 2018) 
using data from sixty-five countries and 2,560 ART clinics showed that ‘large disparities exist with ICSI 
used in nearly 97% of Middle East cycles compared with 55% in Asia and 69% in Europe’. The first report 
of ART in Africa (Dyer et al. 2019) documented that 89% of aspirations were using ICSI (19,207/21,238 
aspirations).  According to the CDC, for women under 35 years of age the majority of fresh, non-donor 
retrievals (68.9%) which used ICSI were ‘without male factor’ (CDC 2016). Clearly, ICSI use for non-male 
factor is widespread.
The justifications for the use of ICSI in non-male factor cases e.g. advanced maternal age, potential failed 
fertilisation, unexplained infertility, cycles with few oocytes etc. and the counterarguments are well 
rehearsed (Evers 2016; Mortimer & Mortimer 2020). However, it is important to recognize that the 
overwhelming majority of published data show no clinical benefit for ICSI use in non-male factor cases. 
For example, Li and colleagues examined a population-based cohort of 14,693 women in Victoria, 
Australia between July 2009 and June 2014. They concluded that ICSI resulted in similar cumulative live 
birth rate compared to IVF for couples with non-male factor infertility (Li et al. 2018).  More recently, 
Sustar et al. (2019) analysed 3,363 stimulated cycles (IVF = 1661; ICSI = 1702) and concluded that use of 
ICSI in normozoospermic men may result in lower clinical pregnancy and live birth rates.
Irrespective of this, there are key questions, as yet unanswered, that need to be addressed to minimize 
unnecessary treatment whilst maximizing success. Firstly, how do we appropriately select men with male 
factor infertility? Traditionally male factor infertility has been diagnosed using basic semen parameters 
and the limitations of this approach are outlined above (section 1.1). To date we have little data on more 
appropriate methods to diagnose the male (see section 1.2) and this makes the identification of those 
cases that are most suitable for ICSI very challenging and of course is a key argument used to justify ICSI 
for all. Nevertheless, it is critical we develop tools to diagnose the male in a more robust manner so that 
appropriate rational therapy can be applied. Furthermore, even when ICSI might be deemed appropriate, 
despite decades of research we still have little idea how to select the best spermatozoon for injection 
(Sakkas et al. 2015; Miller et al. 2019).  Secondly, what are the long-term consequences of ICSI treatment? 
Even though initial data are relatively reassuring (Berntsen et al. 2019; Catford et al. 2018), there is an 
urgent need, as expressed by the WHO Evidence Synthesis Group, to examine the long-term health 
outcomes of the children born from men with compromised fertility whatever the nature of the 
compromising event(s) (e.g. genetics, environmental, iatrogenic and/or occupational) (Barratt et al. 2017).  
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remains: are there are any additional risks from the procedure itself (Mortimer & Mortimer 2020; 
Rumbold et al., 2019)? 
5. Discussion.
The consensus group discussed the issue of semen analysis at length. It was agreed that basic semen 
analysis provides diagnostic but little functional information and that progress in assessment of sperm 
function over the last 25 years has been very limited and disappointing. Areas of major concern were the 
persistence of large variation between laboratories in the quality of semen analysis (including poor 
technical standards and failure to comply with WHO guidelines) and inconsistencies and confusion 
regarding interpretation of the data.  The question of failure to follow WHO guidelines suggests that 
training and quality control measures are not effective. There is a real and immediate need to address this 
problem at national and international levels.  Possibilities discussed included a regulatory requirement for 
trained andrologist in every clinic (which is already the case in some countries) and incorporating semen 
analysis standards into laboratory inspection and training. There was also an extended discussion about 
the use of WHO semen analysis reference ranges as cut-offs and the urgent need to accept and to explain 
to patients that semen analysis allows estimation of probability of successful conception/IVF fertilization 
but is very often not a yes/no diagnosis.
The discussion of functional tests mostly concerned the usefulness of those already available. Should tests 
of DNA fragmentation be used only in specific circumstances, for example patients who have had 
chemotherapy? Should such tests be used at all since there is no corrective  treatment available?  Some 
members of the group felt that patients wanted to know what was wrong – whereas others reported that 
patients attending their clinic just want a healthy child. As with semen analysis, there is inter-laboratory 
variation in testing and there might be benefit in having regional, specialized testing centres. There was 
universal agreement that development of simple, cost-effective functional tests should continue to be an 
objective for researchers and industry, particularly aiming for   accuracy and ease of use through 
automation. Furthermore, since most tests are destructive (providing information about the sample 
population but not about the actual cell(s) tested), development of non-destructive tests that provide 
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There was acceptance that the evidence for a progressive fall in human sperm counts was becoming much 
stronger and that there was a need for further research, both to widen the range of populations 
investigated (nearly all data  currently concern  western men) and to resolve doubts regarding the nature 
of the observed trend. In particular, prospective studies should be carried out. Another significant point 
raised in discussion was that the data suggest that birth year is more important than year of testing, 
suggesting that the factors responsible for the observed decline might exert major effects on 
development of testicular capacity in utero. A number of issues discussed related to both 
environmental/lifestyle influences and occupational exposure, including the importance of realizing that 
exposures are often to mixtures of chemicals/toxicants and that significant interactions and synergistic 
effects might occur. Also, the effects of exposures to these compounds must be considered within their 
genetic background, both when developing hypotheses and designing studies, which will require global 
collaboration. Another area of significant discussion was the need for balanced communication of 
concerns to governments and to the public – which requires use of the ‘collaborative engagement’ model.  
Surprisingly there are very few examples of a coordinated approach to male reproductive health. The best 
example is that of, ‘Healthy Male’ (formerly Andrology Australia https://www.healthymale.org.au/) 
coordinated by the Australian Government. Unfortunately other governments/national societies have not 
followed this comprehensive approach. 
A key factor identified during the discussion was the lack of a quantitative, detailed assessment of the 
economic and societal burden of male reproductive health. For almost all other diseases, compelling 
evidence of economic effect has been presented, but no such analysis has been undertaken for male 
reproductive health (see Barratt et al., 2018). An accurate economic impact assessment is fundamental to 
underpin scientific arguments and modify policy. A good example of such analysis is that of weather 
forecasting. Alley and colleagues argued that investment in accurate weather prediction models paid 
economic dividends ranging from 3 to 10 times the amount invested  (Alley et al., 2019).  The World Bank 
report on funding of weather forecasting suggested that meeting a worldwide investment need of 1.5-2 
US$ billion and ongoing annual costs of ~500 million could save 23,000 lives per year and would achieve 
up to US$ 30 billion per year in economic  benefits (Alley et al., 2019).  These are powerful statements 
that help highlight the impact of a discipline to policy makers.  
The consensus group agreed that advice about  the effects of  life exposures on fertility had value but also 
felt that, although there was clear evidence for effects of lifestyle/behavior prior to attempting to 
conceive,  the evidence for improvement after intervention e.g. giving up smoking was poor. More 
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is needed to guide the use of therapies such as antioxidants for the reduction of oxidative stress. Could 
there be a sub-population that  would benefit from such therapy (potentially related to genetic 
background) and might there even be a sub-population for whom free-radical levels were already 
unusually low such that they should not be further lowered? Development of robust routine testing of 
semen for free radicals/oxidative stress is needed.
A fundamental point that was raised in many of the presentations and throughout the discussion was the 
need, in almost all areas, for large, high quality robust studies, including well-controlled RCTs.
Following presentation of evidence, debate and discussion the group identified a series of 36 consensus 
points. One important objective of providing these is for them to provide clear statements of evidence 
gaps and/or potential future research areas/topics. Appropriate funding streams addressing these can 
then be prioritized and consequently, in the short and medium term, answers can provided.  By using this 
strategic approach our discipline can make the rapid progress necessary to address key scientific, clinical 
and societal questions that do and will face us. 
6. Consensus points. 
1. Male subfertility is a complex and heterogeneous condition. The development of robust diagnostics 
and treatment interventions should ultimately allow development of individualized approaches to 
patient care.
2. A detailed economic impact assessment of the costs of male subfertility and infertility is urgently 
needed.
3. There is a need for prospective collection of quality semen analysis data from global sources to 
improve clinical and health policy decision-making.
4. Threshold values for semen analysis have an acceptable specificity but low sensitivity for identifying 
male (sub)fertility. Therefore, caution should be used in the interpretation of results in relation to the 
WHO manual reference values.
5. Semen quality is not just a matter of reproductive potential. There is an emerging clinical issue 
related to the higher morbidity (including cancer) and lower life expectancy in subfertile men relative 
to the general population. Recent studies have revealed genetic links in some cases. The 
identification of co-morbidities needs to be the subject of prospective studies.
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7. Interpretation of semen analysis for diagnosis of male sub-fertility is more predictive when several 
semen characteristics are considered together.
8. There is a clear need for training and education, at the national and international level, of laboratory 
personnel performing semen analysis, leading to individual certification. This requires effective 
maintenance of competence, internal quality control, and external quality assurance programs.
9. There is a need to develop accurate, automated methods for semen analysis and testing sperm 
functional potential. This could include development of point-of-care devices that have been fully 
validated, and include accompanying QC/QA tools.
10. Definitions of the specific quality expectations and performance of QC/QA programs in laboratory 
andrology are needed. 
11. At present, most sperm function tests are too technically complex and/or expensive for routine use. 
Simpler, robust, cost-effective tests are needed, with validated, prospective clinical endpoint data to 
support the interpretation of results.
12. Sperm DNA fragmentation is higher in some men with subfertility. However, the range of tests and 
variations in protocols, as well as a general lack of test-specific validated threshold values, continues 
to limit its potential clinical utility. Large-scale, prospective clinical studies are needed.
13. Research efforts should be focused on the development of non-destructive tests of sperm function 
that allow the tested sperm to be selected and used in the attempt to establish a pregnancy
14. The studies that show a decline in sperm count raise concerns with regard to future male fertility and 
health. However, they are potentially influenced by the assessment methods that were used. 
Therefore, prospective studies using rigorously standardized methodology are warranted.
15. These prospective studies should take into account that the birth year is likely to have more influence 
on the result than the year in which the test was performed. This is because it is likely that in utero 
exposures influence testicular functional capacity that can then be further affected by personal and 
environmental exposures.
16. Male reproductive health studies that take into account the interaction between environmental 
exposures and genetic background should be conducted.
17. High quality epidemiological studies in diverse populations are needed to better identify 
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18. Mixtures of chemicals and additional exposures should be taken into consideration when studying 
their effect(s) on male reproductive health. Caution is urged in relation to studies of individual 
chemicals or single exposures. 
19. Pharmaceutical reference sources need to include more information on potential adverse effects on 
male reproductive health.
20. There is a need to develop effective methods and engagement strategies to provide information 
about male reproductive health to the public, regulators, and policy-makers.
21. There are few effective medical interventions for male infertility. Hypogonadotropic hypogonadism is 
a well-defined condition that responds to hormonal treatment.
22. In general, there is no good quality evidence to support empirical hormonal treatment for idiopathic 
oligozoospermia or unexplained male subfertility. Large-scale studies are needed to identify who 
could benefit from this type of treatment; a clinical endpoint of such studies should be live birth rate.
23. Exogenous testosterone treatment should not be used in an attempt to improve sperm production as 
it has a negative effect on spermatogenesis.
24. Since medical professional societies have already addressed the controversial topic of varicocele 
treatment, the Group elected not to consider it further.
25. TESE and micro-TESE are ways of obtaining spermatozoa in some, but not all men with non-
obstructive azoospermia. Only a few markers are known to predict poor TESE outcome (e.g. Y-
chromosome microdeletions) therefore, additional markers are needed to identify those who would 
benefit from this procedure.
26. A better understanding of the etiology of spermatogenic arrest is needed to identify and develop 
treatments for affected men.
27. Future research should focus on finding simple, cost-effective screening technologies for male genital 
tract infection.
28. Smoking negatively affects personal and reproductive health. Patients should be offered smoking 
cessation strategies to minimize exposure to tobacco smoke and vaping.
29. Oxidative stress is a recognized pathology in male subfertility. Dietary and vitamin supplements 
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supplementation is an effective intervention. Further, well-designed, large-scale randomized 
controlled trials are needed.
30. The use of intimate lubricants should be recommended with caution since many are toxic to sperm. If 
a coital lubricant is needed, products established as being “sperm friendly” should be used.
31. Genetic testing in azoospermia, severe oligozoospermia, total lack of sperm motility, and 
monomorphic teratozoospermia has diagnostic and prognostic value, and is important for genetic 
counselling. 
32. With the current diagnostic tests, there is still a large proportion of idiopathic NOA/OAT cases who 
are likely to be affected by undefined genetic factors. Exome / genome analysis studies have the 
potential to develop a gene panel to enhance diagnosis and pre-TESE prognosis in such men.
33. The current data do not support the use of ICSI for non-male factor patients.
34. Not all cases of male factor infertility justify treatment by ICSI; some could be treated using IUI or IVF.
35. The potential risks of the indiscriminate use of ICSI to the health of children have yet to be firmly 
established. High-quality longitudinal studies are therefore required. 
36. Given concerns related to the indiscriminate use of ICSI, more research is required to better 
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